Skip to main content
Top
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery 4/2018

01-12-2018 | Original Article

Understanding Malignancies of the Thyroid Gland: Institutional Experience

Authors: Jaimanti Bakshi, Sourabha Kumar Patro, Navjot Kaur, Naresh Kumar Panda, Grace Budhiraja

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Issue 4/2018

Login to get access

Abstract

To study the epidemiological, pathological characters and determine survival in patients diagnosed of having thyroid gland malignancies. Retrospective chart review of patients having thyroid gland malignancies, which were managed by the two senior authors at our tertiary care institute from January 2000 to December 2006, were performed and evaluated in terms of various clinical, operative and histological parameters. Patients in which follow up of at least 10 years are available were included in the study. Survival was enquired telephonically in those patients who got cured and did not consent to come for follow up. Slides were reviewed. Statistical analysis was done using SPSS statistical software. Kaplan–Meier method was used for calculating survival. A total of 182 patients were included in the study. Papillary carcinoma was the commonest malignant lesion with a frequency of 87.91% followed by follicular carcinoma (7.69%), medullary carcinoma (3.29%) and anaplastic carcinoma (1.09%). Female predominance was seen (F:M–5.06:1). The 5 year and 10 year survival rates were 89% and 73% respectively. The most common postoperative squeal was transient hypocalcaemia, seen in (27/182) 15% patients which was followed by permanent hypocalcaemia 16/182 (8.79%), transient recurrent laryngeal nerve paresis 12/182 (6.59%) and permanent recurrent laryngeal nerve palsy 8/182 (4.39%). Thyroid malignancies affect all age groups and have good long term prognosis. Management yields promising results and hence early and adequate treatment is emphasized.
Literature
1.
go back to reference Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12(1):20–37CrossRef Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12(1):20–37CrossRef
2.
go back to reference Ron E, Lubin JH, Shore RE et al (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141(3):259–277CrossRef Ron E, Lubin JH, Shore RE et al (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141(3):259–277CrossRef
3.
go back to reference Schneider AB, Bekerman C, Leland J et al (1997) Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab 82(12):4020–4027PubMed Schneider AB, Bekerman C, Leland J et al (1997) Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab 82(12):4020–4027PubMed
4.
go back to reference Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 [see comments]. Cancer 83(12):2638–2648CrossRef Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 [see comments]. Cancer 83(12):2638–2648CrossRef
5.
go back to reference Tunbridge WM, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7(6):481–493CrossRef Tunbridge WM, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7(6):481–493CrossRef
6.
go back to reference Vander JB, Gaston EA, Dawber TR (1968) The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69(3):537–540CrossRef Vander JB, Gaston EA, Dawber TR (1968) The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69(3):537–540CrossRef
7.
go back to reference Hegedus L (2004) Clinical practice. The thyroid nodule. N Engl J Med 351(17):1764–1771CrossRef Hegedus L (2004) Clinical practice. The thyroid nodule. N Engl J Med 351(17):1764–1771CrossRef
8.
go back to reference Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2):109–142CrossRef Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2):109–142CrossRef
9.
go back to reference Mandel SJ (2004) A 64-year-old woman with a thyroid nodule. JAMA 292(21):2632–2642CrossRef Mandel SJ (2004) A 64-year-old woman with a thyroid nodule. JAMA 292(21):2632–2642CrossRef
10.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249CrossRef Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249CrossRef
11.
go back to reference Ferlay J (2000) Cancer IAfRo. GLOBOCAN, Cancer incidence, mortality and prevalence worldwide. IARC Press, Lyon Ferlay J (2000) Cancer IAfRo. GLOBOCAN, Cancer incidence, mortality and prevalence worldwide. IARC Press, Lyon
12.
go back to reference Altekruse S, Das A, Cho H, Petkov V, Yu M (2015) Do US thyroid cancer incidence rates increase with socioeconomic status among people with health insurance? An observational study using SEER population-based data. BMJ Open 5(12):e009843CrossRef Altekruse S, Das A, Cho H, Petkov V, Yu M (2015) Do US thyroid cancer incidence rates increase with socioeconomic status among people with health insurance? An observational study using SEER population-based data. BMJ Open 5(12):e009843CrossRef
13.
14.
go back to reference Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428CrossRef Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428CrossRef
15.
go back to reference Jonklaas J, Nogueras-Gonzalez G, Munsell M et al (2012) The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab 97(6):E878–E887CrossRef Jonklaas J, Nogueras-Gonzalez G, Munsell M et al (2012) The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab 97(6):E878–E887CrossRef
16.
go back to reference Ushenkova LN, Koterov AN, Biryukov AP (2015) Pooled analysis of RET/PTC gene rearrangement rate in sporadic and radiogenic thyroid papillary carcinoma. Radiat Biol Radioecol 55(4):355–388 Ushenkova LN, Koterov AN, Biryukov AP (2015) Pooled analysis of RET/PTC gene rearrangement rate in sporadic and radiogenic thyroid papillary carcinoma. Radiat Biol Radioecol 55(4):355–388
17.
go back to reference Sozzi G, Bongarzone I, Miozzo M et al (1992) Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas. Genes Chromosomes Cancer 5(3):212–218CrossRef Sozzi G, Bongarzone I, Miozzo M et al (1992) Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas. Genes Chromosomes Cancer 5(3):212–218CrossRef
18.
go back to reference Tarashchenko YN, Kovalenko AE, Bolgov MY et al (2015) Braf-status of papillary thyroid carcinomas and strategy of surgical treatment. Klin Khir 6:49–54 Tarashchenko YN, Kovalenko AE, Bolgov MY et al (2015) Braf-status of papillary thyroid carcinomas and strategy of surgical treatment. Klin Khir 6:49–54
19.
go back to reference Jiang L, Chu H, Zheng H (2016) B-Raf mutation and papillary thyroid carcinoma patients. Oncol Lett 11(4):2699–2705CrossRef Jiang L, Chu H, Zheng H (2016) B-Raf mutation and papillary thyroid carcinoma patients. Oncol Lett 11(4):2699–2705CrossRef
20.
go back to reference Kitamura Y, Shimizu K, Tanaka S, Emi M (1999) Genetic alterations in thyroid carcinomas. Nihon Ika Daigaku Zasshi. 66(5):319–323CrossRef Kitamura Y, Shimizu K, Tanaka S, Emi M (1999) Genetic alterations in thyroid carcinomas. Nihon Ika Daigaku Zasshi. 66(5):319–323CrossRef
21.
go back to reference Song YS, Lim JA, Park YJ (2015) Mutation profile of well-differentiated thyroid cancer in Asians. Endocrinol Metab (Seoul) 30(3):252–262CrossRef Song YS, Lim JA, Park YJ (2015) Mutation profile of well-differentiated thyroid cancer in Asians. Endocrinol Metab (Seoul) 30(3):252–262CrossRef
22.
go back to reference Sobrinho-Simoes M, Preto A, Rocha AS et al (2005) Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch 447(5):787–793CrossRef Sobrinho-Simoes M, Preto A, Rocha AS et al (2005) Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch 447(5):787–793CrossRef
23.
go back to reference Grubbs EG, Rich TA, Li G et al (2008) Recent advances in thyroid cancer. Curr Probl Surg 45(3):156–250CrossRef Grubbs EG, Rich TA, Li G et al (2008) Recent advances in thyroid cancer. Curr Probl Surg 45(3):156–250CrossRef
24.
go back to reference Majumder KR, Karmakar R, Karim SS, Al-Mamun A (2016) Malignancy in solitary thyroid nodule. Mymensingh Med J 25(1):39–44PubMed Majumder KR, Karmakar R, Karim SS, Al-Mamun A (2016) Malignancy in solitary thyroid nodule. Mymensingh Med J 25(1):39–44PubMed
25.
go back to reference Frates MC, Benson CB, Charboneau JW et al (2005) Management of thyroid nodules detected at US: Society of radiologists in ultrasound consensus conference statement. Radiology 237(3):794–800CrossRef Frates MC, Benson CB, Charboneau JW et al (2005) Management of thyroid nodules detected at US: Society of radiologists in ultrasound consensus conference statement. Radiology 237(3):794–800CrossRef
26.
go back to reference Brander AE, Viikinkoski VP, Nickels JI, Kivisaari LM (2000) Importance of thyroid abnormalities detected at US screening: a 5-year follow-up. Radiology 215(3):801–806CrossRef Brander AE, Viikinkoski VP, Nickels JI, Kivisaari LM (2000) Importance of thyroid abnormalities detected at US screening: a 5-year follow-up. Radiology 215(3):801–806CrossRef
27.
go back to reference Baloch ZW, Cibas ES, Clark DP et al (2008) The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 5:6CrossRef Baloch ZW, Cibas ES, Clark DP et al (2008) The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 5:6CrossRef
28.
go back to reference Cibas ES, Ali SZ (2009) The bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132(5):658–665CrossRef Cibas ES, Ali SZ (2009) The bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132(5):658–665CrossRef
29.
go back to reference Bestepe N, Ozdemir D, Tam AA et al (2016) Malignancy risk and false-negative rate of fine needle aspiration cytology in thyroid nodules ≥ 4.0 cm. Surgery 160:405–412CrossRef Bestepe N, Ozdemir D, Tam AA et al (2016) Malignancy risk and false-negative rate of fine needle aspiration cytology in thyroid nodules ≥ 4.0 cm. Surgery 160:405–412CrossRef
30.
go back to reference Cao H, Kao RH, Hsieh MC (2016) Comparison of core-needle biopsy and fine-needle aspiration in screening for thyroid malignancy: a systematic review and meta-analysis. Curr Med Res Opin 32:1291–1301CrossRef Cao H, Kao RH, Hsieh MC (2016) Comparison of core-needle biopsy and fine-needle aspiration in screening for thyroid malignancy: a systematic review and meta-analysis. Curr Med Res Opin 32:1291–1301CrossRef
31.
go back to reference Yeh MW, Demircan O, Ituarte P, Clark OH (2004) False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid 14(3):207–215CrossRef Yeh MW, Demircan O, Ituarte P, Clark OH (2004) False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid 14(3):207–215CrossRef
32.
go back to reference Barabadze E, Burkadze G, Munjishvili V (2016) Accurate diagnosis of thyroid nodules: a review of diagnostic dilemmas on thyroid fine-needle aspiration biopsies. Georgian Med News 252:89–95 Barabadze E, Burkadze G, Munjishvili V (2016) Accurate diagnosis of thyroid nodules: a review of diagnostic dilemmas on thyroid fine-needle aspiration biopsies. Georgian Med News 252:89–95
33.
go back to reference Layfield LJ, Cibas ES, Gharib H, Mandel SJ (2009) Thyroid aspiration cytology: current status. CA Cancer J Clin 59(2):99–110CrossRef Layfield LJ, Cibas ES, Gharib H, Mandel SJ (2009) Thyroid aspiration cytology: current status. CA Cancer J Clin 59(2):99–110CrossRef
34.
go back to reference Al-Qurayshi Z, Hauch A, Srivastav S, Aslam R, Friedlander P, Kandil E (2016) A national perspective of the risk, presentation, and outcomes of pediatric thyroid cancer. JAMA Otolaryngol Head Neck Surg 142:472–478CrossRef Al-Qurayshi Z, Hauch A, Srivastav S, Aslam R, Friedlander P, Kandil E (2016) A national perspective of the risk, presentation, and outcomes of pediatric thyroid cancer. JAMA Otolaryngol Head Neck Surg 142:472–478CrossRef
35.
go back to reference Eichhorn W, Tabler H, Lippold R, Lochmann M, Schreckenberger M, Bartenstein P (2003) Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution. Thyroid 13(10):949–958CrossRef Eichhorn W, Tabler H, Lippold R, Lochmann M, Schreckenberger M, Bartenstein P (2003) Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution. Thyroid 13(10):949–958CrossRef
36.
go back to reference Veronese N, Luchini C, Nottegar A et al (2015) Prognostic impact of extra-nodal extension in thyroid cancer: a meta-analysis. J Surg Oncol 112(8):828–833CrossRef Veronese N, Luchini C, Nottegar A et al (2015) Prognostic impact of extra-nodal extension in thyroid cancer: a meta-analysis. J Surg Oncol 112(8):828–833CrossRef
37.
go back to reference Mazzaferri EL (1993) Management of a solitary thyroid nodule. N Engl J Med 328(8):553–559CrossRef Mazzaferri EL (1993) Management of a solitary thyroid nodule. N Engl J Med 328(8):553–559CrossRef
38.
go back to reference Pingpank JF Jr, Sasson AR, Hanlon AL, Friedman CD, Ridge JA (2002) Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: a common occurrence. Arch Otolaryngol Head Neck Surg 128(11):1275–1278CrossRef Pingpank JF Jr, Sasson AR, Hanlon AL, Friedman CD, Ridge JA (2002) Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: a common occurrence. Arch Otolaryngol Head Neck Surg 128(11):1275–1278CrossRef
39.
go back to reference Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA (1988) Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 67(3):501–508CrossRef Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA (1988) Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 67(3):501–508CrossRef
40.
go back to reference Sisson JC, Giordano TJ, Jamadar DA et al (1996) 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma. Cancer 78(10):2184–2192CrossRef Sisson JC, Giordano TJ, Jamadar DA et al (1996) 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma. Cancer 78(10):2184–2192CrossRef
41.
go back to reference Haigh PI, Urbach DR, Rotstein LE (2005) Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol 12(1):81–89CrossRef Haigh PI, Urbach DR, Rotstein LE (2005) Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol 12(1):81–89CrossRef
42.
go back to reference Haigh PI, Urbach DR, Rotstein LE (2004) AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States. Surgery. 136(3):609–616CrossRef Haigh PI, Urbach DR, Rotstein LE (2004) AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States. Surgery. 136(3):609–616CrossRef
43.
go back to reference Jonklaas J, Sarlis NJ, Litofsky D et al (2006) Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16(12):1229–1242CrossRef Jonklaas J, Sarlis NJ, Litofsky D et al (2006) Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16(12):1229–1242CrossRef
44.
go back to reference Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246(3):375–381 (discussion 381–374) CrossRef Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246(3):375–381 (discussion 381–374) CrossRef
45.
go back to reference McDougall IR, Hay ID (2007) ATA guidelines: do patients with stage I thyroid cancer benefit from (131)I? Thyroid 17(6):595–596 (author reply 596–597) CrossRef McDougall IR, Hay ID (2007) ATA guidelines: do patients with stage I thyroid cancer benefit from (131)I? Thyroid 17(6):595–596 (author reply 596–597) CrossRef
46.
go back to reference Eustatia-Rutten CF, Romijn JA, Guijt MJ et al (2003) Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 88(7):3184–3189CrossRef Eustatia-Rutten CF, Romijn JA, Guijt MJ et al (2003) Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 88(7):3184–3189CrossRef
47.
go back to reference Muresan MM, Olivier P, Leclere J et al (2008) Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer 15(1):37–49CrossRef Muresan MM, Olivier P, Leclere J et al (2008) Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer 15(1):37–49CrossRef
48.
go back to reference Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS (2001) A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 91(3):505–524CrossRef Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS (2001) A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 91(3):505–524CrossRef
49.
go back to reference Lopez-Penabad L, Chiu AC, Hoff AO et al (2003) Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer 97(5):1186–1194CrossRef Lopez-Penabad L, Chiu AC, Hoff AO et al (2003) Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer 97(5):1186–1194CrossRef
50.
go back to reference Herrera MF, Hay ID, Wu PS et al (1992) Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg. 16(4):669–674 (discussion 774–665) CrossRef Herrera MF, Hay ID, Wu PS et al (1992) Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg. 16(4):669–674 (discussion 774–665) CrossRef
51.
go back to reference Block MA (1990) Surgical treatment of medullary carcinoma of the thyroid. Otolaryngol Clin N Am 23(3):453–473 Block MA (1990) Surgical treatment of medullary carcinoma of the thyroid. Otolaryngol Clin N Am 23(3):453–473
52.
go back to reference Are C, Shaha AR (2006) Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 13(4):453–464CrossRef Are C, Shaha AR (2006) Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 13(4):453–464CrossRef
53.
go back to reference Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A (2005) Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 103(7):1330–1335CrossRef Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A (2005) Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 103(7):1330–1335CrossRef
54.
go back to reference Untch BR, Olson JA Jr (2006) Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid. Surg Oncol Clin N Am 15(3):661–679CrossRef Untch BR, Olson JA Jr (2006) Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid. Surg Oncol Clin N Am 15(3):661–679CrossRef
55.
go back to reference Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA (1990) Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 66(2):321–330CrossRef Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA (1990) Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 66(2):321–330CrossRef
56.
go back to reference Kwon J, Kim BH, Jung HW, Besic N, Sugitani I, Wu HG (2016) The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: a systematic review and meta-analysis. Eur J Cancer 59:34–45CrossRef Kwon J, Kim BH, Jung HW, Besic N, Sugitani I, Wu HG (2016) The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: a systematic review and meta-analysis. Eur J Cancer 59:34–45CrossRef
57.
go back to reference Lennon P, Deady S, Healy ML et al (2016) Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy. Head Neck 38(Suppl 1):E1122–E1129CrossRef Lennon P, Deady S, Healy ML et al (2016) Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy. Head Neck 38(Suppl 1):E1122–E1129CrossRef
Metadata
Title
Understanding Malignancies of the Thyroid Gland: Institutional Experience
Authors
Jaimanti Bakshi
Sourabha Kumar Patro
Navjot Kaur
Naresh Kumar Panda
Grace Budhiraja
Publication date
01-12-2018
Publisher
Springer India
Published in
Indian Journal of Otolaryngology and Head & Neck Surgery / Issue 4/2018
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-018-1492-3

Other articles of this Issue 4/2018

Indian Journal of Otolaryngology and Head & Neck Surgery 4/2018 Go to the issue